NO164242C - Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater. - Google Patents

Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.

Info

Publication number
NO164242C
NO164242C NO851921A NO851921A NO164242C NO 164242 C NO164242 C NO 164242C NO 851921 A NO851921 A NO 851921A NO 851921 A NO851921 A NO 851921A NO 164242 C NO164242 C NO 164242C
Authority
NO
Norway
Prior art keywords
imidazo
procedure
rifamycin derivatives
preparing pyrido
pyrido
Prior art date
Application number
NO851921A
Other languages
English (en)
Norwegian (no)
Other versions
NO164242B (no
NO851921L (no
Inventor
Vincenzo Cannata
Egidio Marchi
Gian Franco Tamagnone
Silvano Piani
Original Assignee
Alfa Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Farmaceutici Spa filed Critical Alfa Farmaceutici Spa
Publication of NO851921L publication Critical patent/NO851921L/no
Publication of NO164242B publication Critical patent/NO164242B/no
Publication of NO164242C publication Critical patent/NO164242C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO851921A 1984-05-15 1985-05-14 Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater. NO164242C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03463/84A IT1199374B (it) 1984-05-15 1984-05-15 Processo per la preparazione di pirido-imidazo-rifamicine

Publications (3)

Publication Number Publication Date
NO851921L NO851921L (no) 1985-11-18
NO164242B NO164242B (no) 1990-06-05
NO164242C true NO164242C (no) 1990-09-12

Family

ID=11107845

Family Applications (1)

Application Number Title Priority Date Filing Date
NO851921A NO164242C (no) 1984-05-15 1985-05-14 Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.

Country Status (18)

Country Link
US (1) US4557866A (fi)
EP (1) EP0161534B1 (fi)
JP (1) JPS60252483A (fi)
AR (1) AR241913A1 (fi)
AT (1) ATE46512T1 (fi)
AU (1) AU568934B2 (fi)
CA (1) CA1215708A (fi)
DE (1) DE3573120D1 (fi)
DK (1) DK162647C (fi)
ES (1) ES8603489A1 (fi)
FI (1) FI81101C (fi)
GR (1) GR851144B (fi)
IE (1) IE58392B1 (fi)
IT (1) IT1199374B (fi)
NO (1) NO164242C (fi)
PH (1) PH22007A (fi)
PT (1) PT80446B (fi)
ZA (1) ZA852971B (fi)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6861053B1 (en) * 1999-08-11 2005-03-01 Cedars-Sinai Medical Center Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth
US7048906B2 (en) 1995-05-17 2006-05-23 Cedars-Sinai Medical Center Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
US7078399B2 (en) * 2001-12-13 2006-07-18 Activbiotics, Inc. Sulfhydryl rifamycins and uses thereof
ITMI20032144A1 (it) * 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
US7906542B2 (en) 2004-11-04 2011-03-15 Alfa Wassermann, S.P.A. Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin
US7923553B2 (en) 2003-11-07 2011-04-12 Alfa Wassermann, S.P.A. Processes for the production of polymorphic forms of rifaximin
US7902206B2 (en) 2003-11-07 2011-03-08 Alfa Wassermann, S.P.A. Polymorphic forms α, β and γ of rifaximin
US20080262024A1 (en) * 2003-11-07 2008-10-23 Giuseppe Claudio Viscomi Rifaximin compositions and method of use
US20060210483A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
US8003118B2 (en) * 2005-03-02 2011-08-23 Kodsi Robert E Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis
US20060210492A1 (en) * 2005-03-02 2006-09-21 Kodsi Robert E Use of rifaximin for treatment and prevention of periodontal conditions
ES2522895T3 (es) 2005-03-03 2014-11-19 Alfa Wassermann S.P.A. Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
CN103263668A (zh) 2006-03-09 2013-08-28 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
HUE025306T2 (hu) 2006-08-02 2016-01-28 Salix Pharmaceuticals Inc Sugárterápia által okozott bélgyulladás kezelésére irányuló módszer
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
KR101667534B1 (ko) * 2006-09-22 2016-10-19 씨아이피엘에이 엘티디. 리팍시민
US20080161337A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Chronic Prostatitis
US20080159987A1 (en) * 2007-01-03 2008-07-03 Leonard Weinstock Use of Rifaximin for the Treatment of Restless Legs Syndrome
ITMI20071241A1 (it) * 2007-06-20 2008-12-21 Solmag S P A Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta
US7709634B2 (en) 2007-09-20 2010-05-04 Apotex Pharmachem Inc. Amorphous form of rifaximin and processes for its preparation
KR101674382B1 (ko) 2008-02-25 2016-11-09 샐릭스 파마슈티컬스 리미티드 리팍시민의 형태 및 이의 용도
US8486956B2 (en) * 2008-02-25 2013-07-16 Salix Pharmaceuticals, Ltd Forms of rifaximin and uses thereof
DK2252148T3 (da) 2008-02-26 2019-05-06 Salix Pharmaceuticals Ltd Fremgangsmåder til behandling af irritabel tarmsyndrom
US11779571B2 (en) 2008-02-26 2023-10-10 Salix Pharmaceuticals, Inc. Methods for treating irritable bowel syndrome (IBS)
WO2009137672A1 (en) 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
CN101585843B (zh) * 2008-05-21 2011-07-06 重庆赛诺生物药业股份有限公司 一种利福昔明的制备工艺
EP2350096B1 (en) 2008-10-02 2019-12-11 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
US7928115B2 (en) * 2008-10-02 2011-04-19 Salix Pharmaceuticals, Ltd. Methods of treating travelers diarrhea and hepatic encephalopathy
US20110035232A1 (en) * 2008-10-02 2011-02-10 Salix Pharmaceuticals, Ltd. Methods of treating hepatic encephalopathy
US8916193B2 (en) 2008-12-10 2014-12-23 Cipla Limited Rifaximin complexes
IT1397617B1 (it) * 2009-04-20 2013-01-18 Alfa Wassermann Spa Nuovi derivati della rifamicina
KR20190099100A (ko) 2009-06-02 2019-08-23 샐릭스 파마슈티컬스 리미티드 간성 뇌병증의 치료방법
AU2010292043B2 (en) 2009-09-13 2016-02-25 Salix Pharmaceuticals, Ltd. Methods for treating irritable bowel syndrome (IBS)
MX2012005883A (es) 2009-11-23 2012-10-09 Cipla Ltd Composicion topica en espuma.
WO2011080691A1 (en) 2009-12-28 2011-07-07 Silvio Massimo Lavagna Method for the production of amorphous rifaximin
WO2011103246A1 (en) 2010-02-18 2011-08-25 Salix Pharmaceuticals, Ltd. Methods for treating infection
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
EP2582707A4 (en) * 2010-06-16 2014-01-08 Apotex Pharmachem Inc POLYMORPHIC FORMS OF RIFAXIMINE
KR101887004B1 (ko) 2010-07-12 2018-08-09 샐릭스 파마슈티컬스 리미티드 리팍시민의 제형 및 이의 용도
WO2012035544A2 (en) 2010-09-13 2012-03-22 Sequent Scientific Ltd. A novel polymorphic form of rifaximin and process for its preparation
PT2672970T (pt) 2011-02-11 2018-10-11 Salix Pharmaceuticals Ltd Formas de rifaximina e suas utilizações
AU2012251385A1 (en) 2011-05-02 2013-11-21 Ranbaxy Laboratories Limited Rifaximin dimethylformamide solvate
WO2012155981A1 (en) 2011-05-19 2012-11-22 Friulchem Spa New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
PL2773205T3 (pl) 2011-11-02 2024-09-02 Salix Pharmaceuticals, Inc. Ryfaksymina w leczeniu ustępującej biegunki z przewagą zespołu jelita drażliwego
CA2876737A1 (en) 2012-06-13 2013-12-19 Apotex Pharmachem Inc. Polymorphic forms of rifaximin
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
WO2014140995A2 (en) 2013-03-15 2014-09-18 Alfa Wassermann S.P.A. Method for diagnosing vaginal infections
AU2014229467A1 (en) 2013-03-15 2015-08-06 Alfa Wassermann S.P.A. Rifaximin for use in the treating of vaginal infections.
US20140308350A1 (en) 2013-04-12 2014-10-16 Alfa Wassermann S.P.A. Nsaid administration and related compositions, methods and systems
US9018225B1 (en) 2013-07-26 2015-04-28 Novel Laboratories Rifaximin crystalline forms and methods of preparation thereof
ITMI20131307A1 (it) 2013-08-02 2015-02-02 A M S A Anonima Materie Sint & Affini S P A Processo per la preparazione di refaximina k
CN103509038B (zh) * 2013-09-30 2016-01-20 浙江思贤制药有限公司 一种新晶型利福昔明ζ及其制备方法
ES2621557T3 (es) 2014-03-31 2017-07-04 Euticals S.P.A. Mezcla polimórfica de rifaximina y su uso para la preparación de formulaciones sólidas
MX2016014329A (es) 2014-05-04 2017-02-23 Salix Pharmaceuticals Inc Microbiota ibs y sus usos.
US9938298B2 (en) 2014-05-12 2018-04-10 Alfa Wassermann S.P.A. Solvated crystal form of rifaximin, production, compositions and uses thereof
EP2982764A1 (en) 2014-08-05 2016-02-10 ALFA WASSERMANN S.p.A. Identification of vaginal bacteria
US9988398B2 (en) 2016-06-07 2018-06-05 Cadila Healthcare Limited Crystalline form of rifaximin and process for its preparation
RS63751B1 (sr) 2016-09-30 2022-12-30 Salix Pharmaceuticals Inc Čvrsti disperzioni oblici rifaksimina
MX2019015681A (es) * 2017-06-26 2020-02-26 Biofer Spa Derivados de pirido-imidazo rifamicina como agente antibacteriano.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1154655B (it) * 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica

Also Published As

Publication number Publication date
DE3573120D1 (en) 1989-10-26
NO164242B (no) 1990-06-05
FI81101B (fi) 1990-05-31
AR241913A1 (es) 1993-01-29
DK162647C (da) 1992-04-13
IE851191L (en) 1985-11-15
JPH0469634B2 (fi) 1992-11-06
ATE46512T1 (de) 1989-10-15
DK214685D0 (da) 1985-05-14
ZA852971B (en) 1985-12-24
US4557866A (en) 1985-12-10
JPS60252483A (ja) 1985-12-13
PT80446B (pt) 1987-11-11
PH22007A (en) 1988-05-02
FI851907A0 (fi) 1985-05-14
ES543115A0 (es) 1986-01-01
EP0161534A2 (en) 1985-11-21
IE58392B1 (en) 1993-09-08
NO851921L (no) 1985-11-18
PT80446A (en) 1985-06-01
AU4251585A (en) 1985-11-21
CA1215708A (en) 1986-12-23
GR851144B (fi) 1985-11-25
EP0161534A3 (en) 1987-03-04
IT1199374B (it) 1988-12-30
EP0161534B1 (en) 1989-09-20
AU568934B2 (en) 1988-01-14
IT8403463A0 (it) 1984-05-15
FI81101C (fi) 1990-09-10
DK214685A (da) 1985-11-16
ES8603489A1 (es) 1986-01-01
DK162647B (da) 1991-11-25
FI851907L (fi) 1985-11-16

Similar Documents

Publication Publication Date Title
NO164242C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO850300L (no) Fremgangsmaate for fremstilling av 3-imidazolylmetyl-tetrahydrokarbazolon-derivater
NO874764D0 (no) Fremgangsmaate for fremstilling av 2-aminopurinderivater.
NO860226L (no) Fremgangsmaate for fremstilling av 1-substituert-aryl-1,4-dihydro-4-oksonaftyridin-derivater.
NO851466L (no) Fremgangsmaate for fremstilling av 9a-aza-9a-homoery-tromycin-derivater.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO863608D0 (no) Fremgangsmaate for fremstilling av benzimidazolderivater.
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
NO862860L (no) Fremgangsmaate for fremstilling av poly-4-aminopyrrole-2-karboksamidoderivater.
NO854924L (no) Fremgangsmaate for fremstilling av emulsjoner.
NO164030C (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater.
ES551410A0 (es) Procedimiento de preparar derivados rodaninicos.
NO165107C (no) Fremgangsmaate for fremstilling av pyrido-imidazo-rifamycin-derivater.
NO885435D0 (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO841965L (no) Fremgangsmaate for fremstilling av 1,8-dihydroksy-10-acyl-9-antron-derivater
ES542469A0 (es) Procedimiento de preparar derivados iminotiazolidinicos
NO851550L (no) Fremgangsmaate for fremstilling av imidazolderivater
NO164238C (no) Fremgangsmaate for fremstilling av pyridobenzodiazepinforbindelser.
ES539074A0 (es) Procedimiento de obtencion de nuevos derivados imidazoliletoxiindanicos.
NO870828L (no) FremgangsmŸte for fremstilling av biskarbamater.
ES516880A0 (es) Procedimiento de preparar derivados de p-acilaminofenol.
NO872690L (no) FremgangsmŸte for fremstilling av mercaptoacylprolin.
IT8505129A0 (it) Procedimento per preparare 3-esometilenecefam derivati.
NO864695D0 (no) Fremgangsmaate for fremstilling av 2,2[-bi-1h-imidazoler.
NO874958D0 (no) Fremgangsmaate for fremstilling av 1-aryloksy-3-amino-2-propanoler.

Legal Events

Date Code Title Description
MK1K Patent expired